| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Journal of Virology, November 2007, p. 12515-12524, Vol. 81, No. 22
0022-538X/07/$08.00+0 doi:10.1128/JVI.01481-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Marc Froeschke,1,
Tsanan Giroglou,2
Dorothee von Laer,2 and
Bernhard Dobberstein1*
Zentrum für Molekulare Biologie der Universität Heidelberg, Im Neuenheimer Feld 282, 69120 Heidelberg, Germany,1 Georg Speyer Haus, Institute for Biomedical Research, Frankfurt University Medical School, 60596 Frankfurt, Germany2
Received 6 July 2007/ Accepted 24 August 2007
Insertion of the lymphocytic choriomeningitis virus (LCMV) precursor glycoprotein C (GP-C) into the membrane of the endoplasmic reticulum is mediated by an unusual signal peptide (SPGP-C). It is comprised of 58 amino acid residues and contains an extended hydrophilic N-terminal region, two hydrophobic regions, and a short C-terminal region. After cleavage by signal peptidase, SPGP-C accumulates in cells and virus particles. In the present study, we identified the LCMV SPGP-C as being an essential component of the GP complex and show that the different regions of SPGP-C are required for distinct steps in GP maturation and virus infectivity. More specifically, we show that one hydrophobic region of SPGP-C is sufficient for the membrane insertion of GP-C, while both hydrophobic regions are required for the processing and cell surface expression of the GPs. The N-terminal region of SPGP-C, on the other hand, is essential for pseudoviral infection of target cells. Furthermore, we show that unmyristoylated SPGP-C exposes its N-terminal region to the exoplasmic side. This SPGP-C can promote GP-C maturation but is defective in pseudoviral infection. Myristoylation and topology of SPGP-C in the membrane may thus hold the key to an understanding of the role of SPGP-C in GP-C complex maturation and LCMV infectivity.
Published ahead of print on 5 September 2007.
S.S. and M.F. contributed equally to this work.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|